<DOC>
	<DOCNO>NCT00004070</DOCNO>
	<brief_summary>RATIONALE : Inserting gene interleukin-12 person 's cancer cell may make body build immune response kill tumor cell . PURPOSE : Phase I/II trial study effectiveness gene therapy treat patient unresectable , recurrent , refractory head neck cancer .</brief_summary>
	<brief_title>Gene Therapy Treating Patients With Unresectable , Recurrent , Refractory Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine safety tolerability interleukin-12 gene patient unresectable , recurrent , refractory squamous cell carcinoma head neck . II . Evaluate efficacy regimen patient . OUTLINE : This multicenter study . Patients receive interleukin-12 gene intratumoral injection twice week 1 weekly week 2-7 absence disease progression unacceptable toxicity . PROJECTED ACCRUAL : A total 28-34 patient accrue study .</detailed_description>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Interleukin-12</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven unresectable , recurrent , refractory squamous cell carcinoma head neck Primarily stage III IV Tumor accessible direct injection No tumor involve major blood vessel obstruct airway PATIENT CHARACTERISTICS : Age : 18 Performance status : Karnofsky 70100 % Life expectancy : At least 3 month Hematopoietic : WBC least 3,000/mm3 Platelet count least 50,000/mm3 Hepatic : No prior concurrent active liver disease SGOT SGPT great 3 time upper limit normal ( ULN ) Renal : Creatinine great 1.5 time ULN Cardiovascular : No New York Heart Association class III IV heart disease Pulmonary : No respiratory disease sufficiently influence oxygenation arterial blood Other : At least 2 week since prior infection No concurrent infection No active clinically relevant viral illness No malignancy require treatment study No prior autoimmune disease ( e.g. , rheumatic disease , Crohn 's disease ) No allergy polyvinylpyrrolidone ( PVP ) relate product No prior psychiatric disability No prior seizures Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : No prior viral base gene therapy , recombinant DNA product , bacterial plasmid Chemotherapy : At least 28 day since prior chemotherapy No concurrent chemotherapy No chemotherapy follow period Endocrine therapy : No concurrent corticosteroid Radiotherapy : At least 28 day since prior radiotherapy No concurrent radiotherapy No radiotherapy follow period Surgery : At least 28 day since prior surgery No concurrent surgery No surgery follow period Other : At least 30 day since prior investigational drug No concurrent high dose nonsteroidal antiinflammatory drug No concurrent immunosuppressive drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2001</verification_date>
	<keyword>recurrent metastatic squamous neck cancer occult primary</keyword>
	<keyword>metastatic squamous neck cancer occult primary squamous cell carcinoma</keyword>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
	<keyword>stage III squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent squamous cell carcinoma paranasal sinus nasal cavity</keyword>
</DOC>